Prime Medicine (PRME) EBIT Margin (2024 - 2026)

Prime Medicine posted quarterly EBIT Margin of 5917.52% for Q1 2026, down 231422.0% year-on-year from N/an in Q1 2025, and down 2.02% on a QoQ basis from 5800.48% in Q4 2025.

Prime Medicine (PRME) has 3 years of EBIT Margin data on file, last reported at 5917.52% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin fell 231422.0% year-over-year to 5917.52%; the trailing twelve-month figure through Mar 2026 stood at 5121.76% (up 24792.0% YoY), and the FY2025 full-year result was 4498.06%, up 228930.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 5917.52%, down from 5800.48% in the prior quarter.
  • Across five years, EBIT Margin topped out at 2025.74% in Q4 2024 and bottomed at 25948.33% in Q3 2024.
  • The 3-year median for EBIT Margin is 5293.83% (2025), against an average of 7583.5%.
  • Peak annual rise in EBIT Margin reached 2154237 bps in 2025, while the deepest fall reached 377473 bps in 2025.
  • A 3-year view of EBIT Margin shows it stood at 2025.74% in 2024, then sank by 186 bps to 5800.48% in 2025, then slipped by 2 bps to 5917.52% in 2026.
  • The last three EBIT Margin figures came in at 5917.52% (Q1 2026), 5800.48% (Q4 2025), and 4405.96% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.02%
10 Prime Medicine 601.24 Mn 601.24 Mn - -5,917.52%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,917.52%
Dec 31, 2025 -5,800.48%
Sep 30, 2025 -4,405.96%
Jun 30, 2025 -4,787.17%
Mar 31, 2025 -3,603.30%
Dec 31, 2024 -2,025.74%
Sep 30, 2024 -25,948.33%
Mar 31, 2024 -8,179.53%